Thrombocytosis in patients with malignant pleural mesotheliomia
- 14 October 1986
- Vol. 58 (8) , 1699-1701
- https://doi.org/10.1002/1097-0142(19861015)58:8<1699::aid-cncr2820580820>3.0.co;2-b
Abstract
Thrombocytosis above 40.0 × 104/mm3 occurred in five of six (83%) patients with malignant mesothelioma. In contrast, the incidence of thrombocytosis was 7.5% in patients with lung adenocarcinoma, 12.5%, in squamous cell carcinoma, 5.1% in small cell carcinoma, and 41.7% in large cell carcinoma, respectively. The platelet count in large cell carcinoma was significantly higher than that in other cell types of lung cancer; however, the platelet count in malignant mesothelioma was much higher than that in large cell carcinoma. These results show that the incidence of thrombocytosis seems to be high in malignant mesothelioma, although the mechanism is thus far unknown.This publication has 8 references indexed in Scilit:
- Glycosaminoglycan in malignant pleural mesotheliomaCancer, 1986
- Analysis of hyaluronic acid in the diagnosis of malignant mesotheliomaCancer, 1984
- THE SIGNIFICANCE OF THROMBOCYTOSIS IN PATIENTS WITH CARCINOMA OF THE LUNG1983
- Diffuse Malignant MesotheliomaAnnals of Internal Medicine, 1982
- Pleural mesothelioma presenting as apparent recurrent pulmonary embolismRespiratory Medicine, 1981
- Glycosaminoglycans of pleural mesothelioma: A possible biochemical variant containing chondroitin sulfateCancer, 1981
- Antemortem diagnosis in two cases of malignant peritoneal mesotheliomaThe Lancet Healthy Longevity, 1974